
Conference Coverage
24 days ago
ID Week Highlights Part 1Latest Content

Measles Update: November 20, 2026

EU Approves Sanofi's Rabies Vaccine VaxRabeo for All Age Groups

Phage-Embedded Bacterial Cellulose Dressing Targets Chronic Wound Biofilms

Loss of Measles Elimination Exposes MMR Gaps, Titer Testing Surges in Outbreak Areas

IDSA 2026 AMR Guidance Puts Resistance Mechanisms at Center of Therapy

Shorts










Videos
Contagion Digital Edition









Continuing Medical Education
All News

Here is what clinicians and the public need to know about PAHO’s decision to withdraw US measles elimination status and the outbreaks behind it.

PAHO formally withdraws US measles elimination status after its commission finds endemic transmission reestablished.

The World Health Organization (WHO) confirmed 2 sporadic, camel-linked MERS-CoV infections with both patients recovered and no secondary transmission among 99 traced contacts.

The EMA issued a positive opinion for a 3-month dapivirine vaginal ring for HIV prevention in women and girls aged 16 and older, cutting annual product costs by nearly 60%.

Cefazolin evidenced non-inferiority and probable superiority, as well as greater safety compared to antistaphylococcal penicillins for methicillin-susceptible S aureus bacteremia, in meta-analysis of direct comparison trials.

The CHMP has recommended expanding dolutegravir to term newborns weighing at least 2 kg and dolutegravir/lamivudine to children as young as 3 months, and European Commission decisions are expected in Q1 2027.

The Bundibugyo Ebola outbreak in the Democratic Republic of Congo has reached 11,145 confirmed cases and 5437 deaths, now the second-largest Ebola outbreak on record.

The Pan American Health Organization has reportedly revoked the US measles elimination status after more than 12 months of continuous transmission, as 2026 cases top 5,400, states report 10 deaths, and kindergarten MMR coverage has fallen to 92.4%.

The Peggy Lillis Foundation's CEO and Co-founder Christian Lillis discusses the organization's initiatives for C diff month, and offers a glimpse of the upcoming Scientific Symposium they are hosting next week.

The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.

Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.

Enteric fever (typhoid or paratyphoid fever) infection in travelers returning to the US is likely resistant to ciprofloxacin, and with some cases also resistant to ceftriaxone, CDC investigators advise treatment guided by susceptibility.

The 2026 Antimicrobial Resistance Threats Report from the CDC categorizes 19 bacterial and fungal pathogens by level of threat to health in the US.

Darren Gitelman, MD, senior medical director of the Advocate Memory Center in Park Ridge, discusses findings linking high-dose influenza vaccination to lower Alzheimer disease risk, study limitations, and potential implications for future dementia prevention research.































































































